These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 1897375

  • 1. Cholinergic strategies in the treatment of Alzheimer's disease.
    Davidson M, Stern RG, Bierer LM, Horvath TB, Zemishlani Z, Markofsky R, Mohs RC.
    Acta Psychiatr Scand Suppl; 1991; 366():47-51. PubMed ID: 1897375
    [Abstract] [Full Text] [Related]

  • 2. Manipulation of the cholinergic system.
    Geroldi C, Bianchetti A, Trabucchi M.
    Funct Neurol; 1997; 12(3-4):187-91. PubMed ID: 9218975
    [No Abstract] [Full Text] [Related]

  • 3. [Cholinergic treatment strategies in Alzheimer's disease].
    Kurz A, Rüster P, Romero B, Zimmer R.
    Nervenarzt; 1986 Oct; 57(10):558-69. PubMed ID: 3785472
    [No Abstract] [Full Text] [Related]

  • 4. Treatment of Alzheimer's disease: an evaluation of the cholinergic approach.
    Lemière J, Van Gool D, Dom R.
    Acta Neurol Belg; 1999 Jun; 99(2):96-106. PubMed ID: 10427352
    [Abstract] [Full Text] [Related]

  • 5. Strategies that support declining cholinergic neurotransmission in Alzheimer's disease patients.
    Sirviö J.
    Gerontology; 1999 Jun; 45 Suppl 1():3-14. PubMed ID: 9876213
    [Abstract] [Full Text] [Related]

  • 6. Cholinergic drugs, affective disorders and dementia: problems of clinical research.
    Spiegel R.
    Acta Psychiatr Scand Suppl; 1991 Jun; 366():66-9. PubMed ID: 1897378
    [No Abstract] [Full Text] [Related]

  • 7. What is the rationale for new treatment strategies in Alzheimer's disease?
    Rogawski MA.
    CNS Spectr; 2004 Jul; 9(7 Suppl 5):6-12. PubMed ID: 15241294
    [Abstract] [Full Text] [Related]

  • 8. The cholinergic hypothesis: a historical overview, current perspective, and future directions.
    Bartus RT, Dean RL, Pontecorvo MJ, Flicker C.
    Ann N Y Acad Sci; 1985 Jul; 444():332-58. PubMed ID: 2990293
    [No Abstract] [Full Text] [Related]

  • 9. Biochemical pathology and treatment strategies in Alzheimer's disease: emphasis on the cholinergic system.
    Winblad B, Messamore E, O'Neill C, Cowburn R.
    Acta Neurol Scand Suppl; 1993 Jul; 149():4-6. PubMed ID: 8128837
    [Abstract] [Full Text] [Related]

  • 10. The treatment of cognitive impairment in Alzheimer's disease: beyond the cholinergic approach.
    Davidson M, Stern RG.
    Psychiatr Clin North Am; 1991 Jun; 14(2):461-82. PubMed ID: 2062728
    [Abstract] [Full Text] [Related]

  • 11. Treatment of Alzheimer's disease with cholinergic drugs.
    Kumar V, Calache M.
    Int J Clin Pharmacol Ther Toxicol; 1991 Jan; 29(1):23-37. PubMed ID: 2004862
    [Abstract] [Full Text] [Related]

  • 12. Alzheimer's dementia: recent developments in cholinergic pharmacology.
    Moss DE, Rodriguez LA.
    Tex Med; 1987 Jan; 83(1):32-4. PubMed ID: 3824230
    [No Abstract] [Full Text] [Related]

  • 13. Alzheimer's disease and anaesthesia: implications for the central cholinergic system.
    Fodale V, Quattrone D, Trecroci C, Caminiti V, Santamaria LB.
    Br J Anaesth; 2006 Oct; 97(4):445-52. PubMed ID: 16950812
    [Abstract] [Full Text] [Related]

  • 14. Cholinergic neuropharmacology: an update.
    Palacios JM, Boddeke HW, Pombo-Villar E.
    Acta Psychiatr Scand Suppl; 1991 Oct; 366():27-33. PubMed ID: 1654727
    [Abstract] [Full Text] [Related]

  • 15. [Galantamine: a novel cholinergic agent for Alzheimer's disease].
    Olazarán J, García G.
    Neurologia; 2002 Oct; 17(8):429-36. PubMed ID: 12396973
    [Abstract] [Full Text] [Related]

  • 16. The cerebrovascular role of the cholinergic neural system in Alzheimer's disease.
    Van Beek AH, Claassen JA.
    Behav Brain Res; 2011 Aug 10; 221(2):537-42. PubMed ID: 20060023
    [Abstract] [Full Text] [Related]

  • 17. Cholinergic therapies for Alzheimer's disease: progress and prospects.
    Palmer AM.
    Curr Opin Investig Drugs; 2003 Jul 10; 4(7):820-5. PubMed ID: 14619403
    [Abstract] [Full Text] [Related]

  • 18. Effect of cholinesterase inhibitors on attention.
    Pepeu G, Giovannini MG, Bracco L.
    Chem Biol Interact; 2013 Mar 25; 203(1):361-4. PubMed ID: 23047023
    [Abstract] [Full Text] [Related]

  • 19. Alterations in brain activation during cholinergic enhancement with rivastigmine in Alzheimer's disease.
    Rombouts SA, Barkhof F, Van Meel CS, Scheltens P.
    J Neurol Neurosurg Psychiatry; 2002 Dec 25; 73(6):665-71. PubMed ID: 12438467
    [Abstract] [Full Text] [Related]

  • 20. Muscarinic cholinergic agonists: pharmacological and clinical perspectives.
    Palacios JM, Spiegel R.
    Prog Brain Res; 1986 Dec 25; 70():485-98. PubMed ID: 3554361
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.